z-logo
open-access-imgOpen Access
Development of a human skin commensal microbe for bacteriotherapy of atopic dermatitis and use in a phase 1 randomized clinical trial
Author(s) -
Teruaki Nakatsuji,
Tissa Hata,
Yun Tong,
J Cheng,
Faiza Shafiq,
Anna M. Butcher,
Secilia S. Salem,
Samantha L. Brinton,
Amanda K. Rudman Spergel,
Keli Johnson,
Brett Jepson,
Agustin Calatroni,
Gloria L. David,
Marco Ramírez-Gama,
Patricia A. Taylor,
Donald Y.M. Leung,
Richard L. Gallo
Publication year - 2021
Publication title -
nature medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.536
H-Index - 547
eISSN - 1546-170X
pISSN - 1078-8956
DOI - 10.1038/s41591-021-01256-2
Subject(s) - atopic dermatitis , staphylococcus aureus , medicine , adverse effect , randomized controlled trial , proinflammatory cytokine , clinical endpoint , skin infection , immunology , dermatology , inflammation , microbiology and biotechnology , biology , bacteria , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom